ResMed Free Cash Flow 2010-2024 | RMD
ResMed annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- ResMed free cash flow for the quarter ending June 30, 2024 was 1,301.80, a year-over-year.
- ResMed free cash flow for the twelve months ending June 30, 2024 was , a year-over-year.
- ResMed annual free cash flow for 2024 was $1.302B, a 126.94% increase from 2023.
- ResMed annual free cash flow for 2023 was $0.574B, a 165.19% increase from 2022.
- ResMed annual free cash flow for 2022 was $0.216B, a 65.88% decline from 2021.
| ResMed Annual Free Cash Flow | |
|---|---|
| 2024 | 1,301.80 |
| 2023 | 573.63 |
| 2022 | 216.31 |
| 2021 | 634.01 |
| 2020 | 706.93 |
| 2019 | 390.34 |
| 2018 | 442.45 |
| 2017 | 351.83 |
| 2016 | 489.40 |
| 2015 | 320.68 |
| 2014 | 318.55 |
| 2013 | 339.24 |
| 2012 | 336.02 |
| 2011 | 216.58 |
| 2010 | 131.36 |
| 2009 | 130.95 |
| ResMed Quarterly Free Cash Flow | |
|---|---|
| 2024-06-30 | 1,301.80 |
| 2024-03-31 | 886.57 |
| 2023-12-31 | 505.73 |
| 2023-09-30 | 256.25 |
| 2023-06-30 | 573.63 |
| 2023-03-31 | 370.64 |
| 2022-12-31 | 116.89 |
| 2022-09-30 | 15.61 |
| 2022-06-30 | 216.31 |
| 2022-03-31 | 165.47 |
| 2021-12-31 | 96.48 |
| 2021-09-30 | -93.00 |
| 2021-06-30 | 634.01 |
| 2021-03-31 | 435.39 |
| 2020-12-31 | 265.47 |
| 2020-09-30 | 130.50 |
| 2020-06-30 | 706.93 |
| 2020-03-31 | 394.63 |
| 2019-12-31 | 184.52 |
| 2019-09-30 | 139.69 |
| 2019-06-30 | 390.34 |
| 2019-03-31 | 270.73 |
| 2018-12-31 | 146.16 |
| 2018-09-30 | 35.13 |
| 2018-06-30 | 442.45 |
| 2018-03-31 | 330.65 |
| 2017-12-31 | 194.53 |
| 2017-09-30 | 77.95 |
| 2017-06-30 | 351.83 |
| 2017-03-31 | 229.88 |
| 2016-12-31 | 176.90 |
| 2016-09-30 | 71.68 |
| 2016-06-30 | 489.40 |
| 2016-03-31 | 360.84 |
| 2015-12-31 | 249.29 |
| 2015-09-30 | 108.21 |
| 2015-06-30 | 320.68 |
| 2015-03-31 | 233.21 |
| 2014-12-31 | 152.86 |
| 2014-09-30 | 65.86 |
| 2014-06-30 | 318.55 |
| 2014-03-31 | 221.48 |
| 2013-12-31 | 138.16 |
| 2013-09-30 | 73.67 |
| 2013-06-30 | 339.24 |
| 2013-03-31 | 231.33 |
| 2012-12-31 | 144.27 |
| 2012-09-30 | 64.42 |
| 2012-06-30 | 336.02 |
| 2012-03-31 | 251.12 |
| 2011-12-31 | 174.97 |
| 2011-09-30 | 76.65 |
| 2011-06-30 | 216.58 |
| 2011-03-31 | 159.70 |
| 2010-12-31 | 94.34 |
| 2010-09-30 | 43.81 |
| 2010-06-30 | 131.36 |
| 2010-03-31 | 88.72 |
| 2009-12-31 | 47.12 |
| 2009-09-30 | 50.06 |
| 2009-06-30 | 130.95 |
| 2009-03-31 | 85.86 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.837B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.272B | 26.25 |
| Stryker (SYK) | United States | $140.156B | 32.75 |
| Boston Scientific (BSX) | United States | $123.450B | 37.59 |
| Medtronic (MDT) | Ireland | $115.424B | 17.18 |
| EssilorLuxottica (ESLOY) | France | $105.988B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.352B | 34.60 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $28.913B | 21.97 |
| Terumo (TRUMY) | Japan | $27.831B | 39.31 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.412B | 13.48 |
| Baxter (BAX) | United States | $20.091B | 13.63 |
| Insulet (PODD) | United States | $16.158B | 67.98 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.705B | 0.00 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.972B | 29.73 |
| BellRing Brands (BRBR) | United States | $7.584B | 32.07 |
| Lantheus Holdings (LNTH) | United States | $7.223B | 17.34 |
| ICU Medical (ICUI) | United States | $4.254B | 40.60 |
| Haemonetics (HAE) | United States | $3.749B | 18.55 |
| Perrigo (PRGO) | Ireland | $3.702B | 11.70 |
| Prestige Consumer Healthcare (PBH) | United States | $3.613B | 18.00 |
| TG Therapeutics (TGTX) | United States | $3.590B | 38.02 |
| GN Store Nord (GNNDY) | Denmark | $3.560B | 21.44 |
| Neogen (NEOG) | United States | $3.357B | 35.23 |
| Envista Holdings (NVST) | United States | $3.210B | 17.13 |
| QuidelOrtho (QDEL) | United States | $3.012B | 18.98 |
| Agios Pharmaceuticals (AGIO) | United States | $2.556B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.190B | 36.75 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.172B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.981B | 52.80 |
| AdaptHealth (AHCO) | United States | $1.451B | 10.48 |
| Warby Parker (WRBY) | United States | $1.445B | 0.00 |
| InMode (INMD) | Israel | $1.407B | 8.96 |
| AtriCure (ATRC) | United States | $1.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.124B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.120B | 0.00 |
| Owens & Minor (OMI) | United States | $1.109B | 8.57 |
| Evolus (EOLS) | United States | $1.039B | 0.00 |
| PetIQ (PETQ) | United States | $0.916B | 23.23 |
| Phibro Animal Health (PAHC) | United States | $0.859B | 17.82 |
| National Vision Holdings (EYE) | United States | $0.816B | 25.95 |
| Cresco Labs (CRLBF) | United States | $0.810B | 0.00 |
| Surmodics (SRDX) | United States | $0.557B | 118.21 |
| Valneva SE (VALN) | France | $0.486B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.470B | 14.17 |
| ZimVie (ZIMV) | United States | $0.448B | 41.64 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Jin Medical (ZJYL) | China | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.378B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.341B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
| Biote (BTMD) | United States | $0.311B | 14.32 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.12 |
| Zynex (ZYXI) | United States | $0.250B | 43.83 |
| Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.229B | 15.22 |
| MacroGenics (MGNX) | United States | $0.226B | 0.00 |
| Omeros (OMER) | United States | $0.217B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 20.87 |
| TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.136B | 0.00 |
| Brainsway (BWAY) | Israel | $0.134B | 161.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Veru (VERU) | United States | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.120B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.105B | 10.61 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 23.60 |
| InterCure (INCR) | Israel | $0.090B | 15.15 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Modular Medical (MODD) | United States | $0.071B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| Exagen (XGN) | United States | $0.052B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.050B | 3.25 |
| Apyx Medical (APYX) | United States | $0.043B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Bright Green (BGXX) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.07 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |